64CuCl2treatment: preliminary data on recurrent glioblastoma patients

被引：0
|
作者：
Stanimirovic, D. [1 ]
Milakovic, D. [1 ]
Mijatovic, J. [1 ]
Rakita, I. [1 ]
Vuleta, G. [1 ]
Basile, M. [2 ]
Valentini, S. [2 ]
机构：
[1] Univ Clin Ctr Republ Srpska, Banja Luka, Bosnia & Herceg
[2] ACOM Adv Ctr Oncol Macerata SRL, Montecosaro, MC, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0614
引用
收藏
页码：S673 / S674
页数：2
相关论文
共 50 条
  • [1] First evidence of 64CuCl2 treatment efficacy in recurrent glioblastoma patients
    Stanimirovic, D.
    Milakovic, D.
    Mijatovic, J.
    Rakita, I.
    Vuleta, G.
    Basile, M.
    Valentini, S.
    Valentini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S690 - S690
  • [2] Case report: glioblastoma imaging and therapy with 64CuCl2
    Valentini, G.
    Panichelli, P.
    Villano, C.
    Pigotti, G.
    Martini, D.
    Giacobbi, B.
    Coccetti, D.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [3] Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids
    Pinto, Catarina I. G.
    Branco, Andre D. M.
    Bucar, Sara
    Fonseca, Alexandra
    Abrunhosa, Antero J.
    da Silva, Claudia L.
    Guerreiro, Joana F.
    Mendes, Filipa
    EJNMMI RESEARCH, 2024, 14 (01)
  • [4] Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids
    Catarina I. G. Pinto
    André D. M. Branco
    Sara Bucar
    Alexandra Fonseca
    Antero J. Abrunhosa
    Cláudia L. da Silva
    Joana F. Guerreiro
    Filipa Mendes
    EJNMMI Research, 14
  • [5] A PRELIMINARY DATA REPORT ON A PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA
    Bota, Daniela
    Chung, Jinah
    Carrillo, Jose
    Kong, Xiao-Tang
    Fu, Beverly
    Pretto, Chrystel
    Strik, Ankie
    Schijns, Virgil
    Stathopoulos, Apostolos
    NEURO-ONCOLOGY, 2017, 19 : 109 - 109
  • [6] BEVACIZUMAB AND IRINOTECAN IN THE TREATMENT OF PATIENTS WITH RECURRENT GLIOBLASTOMA
    Naskhletashvili, D. R.
    Gorbounova, V.
    Bychkov, M.
    Bekyashev, A.
    Karakhan, V.
    Aloshin, V.
    Fu, R.
    Moskvina, E.
    NEURO-ONCOLOGY, 2012, 14 : 59 - 59
  • [7] AUTOPSY STUDY ON THE EFFECTS OF TUMOR TREATMENT FIELDS IN RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS
    Barrington, Alexander
    Hurrell, Sarah
    Laviolette, Peter
    NEURO-ONCOLOGY, 2018, 20 : 258 - 258
  • [8] Phase II Study of Bevacizumab in Combination With Temozolomide as Treatment of Patients With Recurrent Glioblastoma Multiforme: Preliminary Analysis of Toxicity
    Sepulveda, J.
    Belda, C.
    Balana, C.
    Perez Segura, P.
    Reynes, G.
    Gil, M.
    Gallego, O.
    Berrocal, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S589 - S589
  • [9] The role of 64CuCl2 PET/CTscan in patients with outspreaded Hodgkin Lymphoma. Is the 64CuCl2 apt to plan a rescue radionuclide therapy?
    Capasso, E., Jr.
    Massidda, S.
    Meleddu, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S483 - S484
  • [10] Radiation dosimetry estimates of 64CuCl2 based on biodistribution data of rats
    Manrique-Arias, Juan
    Carrasco-Hernandez, Jhonatan
    Reyes, Pedro G.
    Avida-Rodraguez, Miguel
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
12345